ECE inhibitor (Bayer)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameECE inhibitor (Bayer)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndothelin-converting enzymes inhibitors
TargetsEndothelin-converting enzymes
Therapy Area/IndicationsHypertensionHeart FailureNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBayer HealthCare AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayer HealthCare AG
Active IndicationsN/A
Inactive IndicationsHypertensionHeart FailureNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A